These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11834904)

  • 1. Thymidine phosphorylase and dihydropyrimidine dehydrogenase in bladder cancer.
    Iizumi T; Hariu K; Sato M; Sato S; Shimizu H; Tomomasa H; Umeda T
    Urol Int; 2002; 68(2):122-5. PubMed ID: 11834904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.
    Mizutani Y; Wada H; Fukushima M; Yoshida O; Ukimura O; Kawauchi A; Miki T
    Eur J Cancer; 2001 Mar; 37(5):569-75. PubMed ID: 11290431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
    Ikeguchi M; Makino M; Kaibara N
    Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
    Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
    Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
    Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.
    Mori K; Hasegawa M; Nishida M; Toma H; Fukuda M; Kubota T; Nagasue N; Yamana H; Hirakawa-YS Chung K; Ikeda T; Takasaki K; Oka M; Kameyama M; Toi M; Fujii H; Kitamura M; Murai M; Sasaki H; Ozono S; Makuuchi H; Shimada Y; Onishi Y; Aoyagi S; Mizutani K; Ogawa M; Nakao A; Kinoshita H; Tono T; Imamoto H; Nakashima Y; Manabe T
    Int J Oncol; 2000 Jul; 17(1):33-8. PubMed ID: 10853015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Bonavida B; Kawauchi A; Miki T
    Oncol Rep; 2002; 9(2):289-92. PubMed ID: 11836594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio in pancreatic cancer].
    Yu XJ; Jiang YJ; Fu DL; Ni QX
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):618-20. PubMed ID: 15634525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
    Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma.
    Morita T; Matsuzaki A; Tokue A
    Oncology; 2003; 65(2):125-31. PubMed ID: 12931018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma: relationship between histological parameters and chemosensitivity to 5-fluorouracil.
    Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Eur Urol; 2003 Jan; 43(1):45-51; discussion 51-2. PubMed ID: 12507543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer.
    Boskos CS; Liacos C; Korkolis D; Aygerinos K; Lamproglou I; Terpos E; Stoupa E; Baltatzis G; Beroukas K; Papasavvas P; Dimopoulos MA; Bamias A
    J Surg Oncol; 2010 Oct; 102(5):408-12. PubMed ID: 19877119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Anticancer Res; 2000; 20(6B):4315-8. PubMed ID: 11205264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
    Hasegawa K; Okamoto H; Kawamura K; Kato R; Kobayashi Y; Sekiya T; Udagawa Y
    Eur J Obstet Gynecol Reprod Biol; 2012 Jul; 163(1):67-70. PubMed ID: 22480411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers.
    Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 May; 11(5):1045-51. PubMed ID: 15069545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells.
    Li G; Kawakami S; Kageyama Y; Yan C; Saito K; Kihara K
    Anticancer Res; 2002; 22(5):2607-12. PubMed ID: 12529971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients.
    Terashima M; Fujiwara H; Takagane A; Abe K; Araya M; Irinoda T; Yonezawa H; Nakaya T; Oyama K; Takahashi M; Saito K
    Eur J Cancer; 2002 Dec; 38(18):2375-81. PubMed ID: 12460781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative endoscopic analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in gastrointestinal cancer.
    Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 Jun; 11(6):1233-9. PubMed ID: 15138561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.